PRIORI, SILVIA GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 20.797
AS - Asia 15.897
EU - Europa 11.970
SA - Sud America 2.199
AF - Africa 470
Continente sconosciuto - Info sul continente non disponibili 432
OC - Oceania 48
Totale 51.813
Nazione #
US - Stati Uniti d'America 20.343
CN - Cina 7.825
SG - Singapore 3.508
IE - Irlanda 2.612
HK - Hong Kong 1.804
UA - Ucraina 1.703
BR - Brasile 1.651
IT - Italia 1.394
DE - Germania 1.268
RU - Federazione Russa 1.201
VN - Vietnam 1.154
FI - Finlandia 922
FR - Francia 857
SE - Svezia 781
GB - Regno Unito 654
IN - India 300
CA - Canada 231
BD - Bangladesh 207
AR - Argentina 185
ZA - Sudafrica 161
JP - Giappone 156
MX - Messico 123
IQ - Iraq 122
PK - Pakistan 103
ID - Indonesia 100
NL - Olanda 92
TR - Turchia 92
AT - Austria 89
EC - Ecuador 80
ES - Italia 75
CO - Colombia 74
PL - Polonia 74
VE - Venezuela 73
UZ - Uzbekistan 66
PH - Filippine 61
MA - Marocco 59
MY - Malesia 42
MU - Mauritius 41
JO - Giordania 40
SA - Arabia Saudita 38
TN - Tunisia 36
CL - Cile 34
AU - Australia 33
PY - Paraguay 33
NP - Nepal 31
EG - Egitto 29
IR - Iran 29
KE - Kenya 28
BE - Belgio 27
PE - Perù 25
IL - Israele 24
JM - Giamaica 24
PT - Portogallo 24
AE - Emirati Arabi Uniti 23
LT - Lituania 22
UY - Uruguay 22
AZ - Azerbaigian 21
CR - Costa Rica 21
DZ - Algeria 20
AL - Albania 19
KZ - Kazakistan 19
ET - Etiopia 18
BO - Bolivia 17
CH - Svizzera 17
TH - Thailandia 16
KR - Corea 14
CZ - Repubblica Ceca 13
EU - Europa 13
GR - Grecia 13
SN - Senegal 13
OM - Oman 12
SK - Slovacchia (Repubblica Slovacca) 12
KW - Kuwait 10
BG - Bulgaria 9
NZ - Nuova Zelanda 9
PA - Panama 9
PS - Palestinian Territory 9
RO - Romania 9
BA - Bosnia-Erzegovina 8
BY - Bielorussia 8
DK - Danimarca 8
LV - Lettonia 8
NI - Nicaragua 8
CG - Congo 7
GE - Georgia 7
HR - Croazia 7
KG - Kirghizistan 7
LB - Libano 7
NO - Norvegia 7
RS - Serbia 7
TW - Taiwan 7
BB - Barbados 6
BW - Botswana 6
GT - Guatemala 6
HN - Honduras 6
SI - Slovenia 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
AO - Angola 5
BH - Bahrain 5
Totale 51.265
Città #
Dublin 2.606
Chandler 2.494
San Jose 2.271
Jacksonville 2.154
Ashburn 1.777
Hong Kong 1.764
Nanjing 1.747
Singapore 1.693
Dallas 1.366
Beijing 1.020
Boardman 987
Nanchang 742
Princeton 651
Lawrence 586
Lauterbourg 559
Wilmington 541
Hebei 530
Changsha 502
Shenyang 462
Los Angeles 435
Ho Chi Minh City 426
Jiaxing 376
Medford 375
Tianjin 319
Helsinki 309
Hanoi 287
San Genesio Ed Uniti 257
Buffalo 256
Council Bluffs 248
Hangzhou 243
New York 241
Moscow 235
Milan 233
Shanghai 213
Woodbridge 198
Redondo Beach 188
Santa Clara 164
São Paulo 141
Tokyo 131
Ann Arbor 125
Verona 113
Johannesburg 110
Norwalk 107
Falls Church 94
Orem 94
The Dalles 93
Nuremberg 91
Seattle 85
Falkenstein 84
Chicago 77
Munich 75
Frankfurt am Main 73
Houston 72
Toronto 67
Montreal 65
Guangzhou 64
San Francisco 64
Brooklyn 62
Des Moines 60
Da Nang 59
Columbus 58
Rio de Janeiro 58
Rome 58
London 56
Kunming 53
Zhengzhou 51
Warsaw 50
Chennai 49
Fairfield 49
Tashkent 48
Washington 44
Baghdad 41
Haiphong 41
Jinan 41
Mexico City 40
Phoenix 40
Atlanta 39
Lahore 39
Stockholm 39
Vienna 38
Amman 36
Belo Horizonte 36
Denver 35
Boston 34
Pavia 34
Naples 31
Ningbo 30
Brasília 29
Dearborn 29
Guayaquil 29
Tappahannock 29
Turku 29
Curitiba 28
Dhaka 28
Amsterdam 27
Salvador 27
Palermo 26
Istanbul 23
Jakarta 23
Nairobi 23
Totale 32.979
Nome #
Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 293
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC HFA EORP Heart Failure Long-Term Registry 233
Calcio antagonisti e aritmie da riperfusione miocardica 208
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 198
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 191
Tachicardia Ventricolare Polimorfa Catecolaminergica 173
A method of gene transfer for the treatment of recessive CPVT 170
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 166
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 161
American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American college of cardiology/european society of cardiology clinical expert consensus documen on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 160
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology 155
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. American College of Cardiology Foundation/American Heart Association Task Force. 152
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 151
La Sindrome di Brugada: aspetti clinici, criteri diagnostici, stratificazione prognostica. 146
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 145
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 143
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 137
La Sindrome di Brugada 137
[Electrophysiologic features of the modulation of ATP-dependent potassium channels]. 136
[Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe]. 136
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 136
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 135
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 133
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 133
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 133
Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. 132
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 132
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary 132
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 132
Beyond Cohort Selection: An Analytics-Enabled i2b2 131
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 130
Gene-specific therapy for inherited arrhythmogenic diseases 130
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy 129
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 129
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 129
Computer simulation of wild-type and mutant human cardiac Na+ current 128
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 127
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website(www.brugadadrugs.org) 126
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 125
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 125
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 125
European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. 124
Catecholaminergic Polymorphic Ventricular Tachycardia. 124
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 124
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 124
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). 124
Evolving determinants of carotid atherosclerosis vulnerability in asymptomatic patients from the MAGNETIC observational study 124
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 123
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 122
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 121
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 120
Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. 120
Risk stratification in the Long-QT Syndrome 119
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 119
Clinical timelines development from textual medical reports in Italian 119
2010 Focused Update of ESC guidelines on device therapy in heart failure: An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 118
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 118
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 118
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 118
A Recessive Variant of the Romano-Ward Long QT Syndrome 117
La Sindrome di Brugada 117
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 117
Genetic causes of sudden cardiac death in the young. 117
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 117
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. 116
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 116
Molecular strategies for the electrophysiologist 115
SUDDEN CARDIAC DEATH 115
Adrenergic Arrhythmogenesis and The Long QT syndrome 115
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 115
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 115
Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 114
[Role of standard resting ECG in the assessment of sudden cardiac death risk] 113
Information extraction from Italian medical reports: An ontology-driven approach 113
Guidelines On Diabetes, Pre-Diabetes, And Cardiovascular Diseases: Executive Summary.The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). 112
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 112
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 112
Molecular genetics: is it making an impact in the management of inherited arrhythmogenic syndromes? 111
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 111
Unexplained cardiac arrest. The need for a prospective registry. 111
2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs 111
Basi genetiche della morte cardiaca improvvisa 110
Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome 110
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 110
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 110
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 109
Universal definition of myocardial infarction. 109
Spotlight on sudden cardiac death 108
Survivors of out-of-hospital cardiac arrest with apparently normal heart: need for definition and standardized clinical evaluation . Consensus statement of the Joint Steering Committees of Unexpleined Cardiac Arrest Registry of Europe and of Idiophatic Ventricular Fibrillation Registry of the United States 108
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 108
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society 107
Cardiac Sodium Channel Diseases 107
Long QT syndrome and catecholaminergic VT 107
Molecular Bases of Juvenile Sudden Cardiac Death. 107
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 106
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 106
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 106
An ICT infrastructure to integrate clinical and molecular data in oncology research. 106
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 105
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model 105
Totale 12.858
Categoria #
all - tutte 231.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 231.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.375 0 6 64 22 53 124 61 138 183 113 372 1.239
2022/20237.411 879 426 86 632 730 835 7 379 3.047 34 229 127
2023/20242.867 308 512 113 276 291 700 128 156 17 84 90 192
2024/20257.508 166 703 206 263 184 284 470 712 1.690 341 644 1.845
2025/202617.123 1.315 1.208 2.229 1.538 1.976 722 3.445 662 1.357 1.412 745 514
2026/2027881 551 330 0 0 0 0 0 0 0 0 0 0
Totale 51.813